XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.25.1

Fair Value Measurements | 3 Months Ended
--- | ---
Mar. 31, 2025
Fair Value Disclosures [Abstract] |
Fair Value Measurements | 5. Fair Value Measurements The carrying amounts of cash and cash equivalents, net accounts receivable, accounts payable and accrued expenses and other current liabilities approximate fair value based on their short-term maturities. With the exception of the Convertible Notes, as discussed in Note 7. Debt, Interest Income, Expense, and Other Finance Costs, the carrying values of our debt and notes receivable approximate fair value as these instruments bear interest either at variable rates or fixed rates, which are not significantly different from market rates. The fair value measurements for our debt and notes receivable are considered to be Level 2 measurements based on the fair value hierarchy. Recurring Fair Value Measurements The following tables present information about our gross assets and liabilities that are measured at fair value on a recurring basis (in millions):
| Fair Value Measurements as of March 31, 2025
| Level 1 Inputs |  | Level 2 Inputs |  | Level 3 Inputs |  | Total
Assets: |  |  |  |  |  |  |
Commodities contracts | $ | 160.3 |  |  | $ | 337.8 |  |  | $ | 7.3 |  |  | $ | 505.4 |
Foreign currency contracts | — |  |  | 13.5 |  |  | — |  |  | 13.5 |
Cash surrender value of life insurance | — |  |  | 19.8 |  |  | — |  |  | 19.8 |
Total assets at fair value | $ | 160.3 |  |  | $ | 371.1 |  |  | $ | 7.3 |  |  | $ | 538.7 |
Liabilities: |  |  |  |  |  |  |
Commodities contracts | $ | 195.4 |  |  | $ | 215.4 |  |  | $ | 4.1 |  |  | $ | 414.9 |
Foreign currency contracts | — |  |  | 21.2 |  |  | — |  |  | 21.2 |
Total liabilities at fair value | $ | 195.4 |  |  | $ | 236.5 |  |  | $ | 4.1 |  |  | $ | 436.1 |
| Fair Value Measurements as of December 31, 2024
| Level 1 Inputs |  | Level 2 Inputs |  | Level 3 Inputs |  | Total
Assets: |  |  |  |  |  |  |
Commodities contracts | $ | 157.4 |  |  | $ | 300.8 |  |  | $ | 9.4 |  |  | $ | 467.6 |
Interest rate contract | — |  |  | 2.9 |  |  | — |  |  | 2.9 |
Foreign currency contracts | — |  |  | 29.1 |  |  | — |  |  | 29.1 |
Cash surrender value of life insurance | — |  |  | 20.0 |  |  | — |  |  | 20.0 |
Total assets at fair value | $ | 157.4 |  |  | $ | 352.8 |  |  | $ | 9.4 |  |  | $ | 519.6 |
Liabilities: |  |  |  |  |  |  |
Commodities contracts | $ | 165.9 |  |  | $ | 209.1 |  |  | $ | 3.7 |  |  | $ | 378.7 |
Foreign currency contracts | — |  |  | 22.9 |  |  | — |  |  | 22.9 |
Total liabilities at fair value | $ | 165.9 |  |  | $ | 232.0 |  |  | $ | 3.7 |  |  | $ | 401.6 |
For our derivative contracts, we may enter into master netting, collateral and offset agreements with counterparties. These agreements provide us the ability to offset a counterparty's rights and obligations, request additional collateral when necessary, or liquidate the collateral in the event of counterparty default. We net the fair value of cash collateral paid or received against fair value amounts recognized for net derivative positions executed with the same counterparty under the same master netting or offset agreement. We have elected to offset the recognized fair value amounts for multiple derivative instruments executed with the same counterparty in our financial statements when a legal right of offset exists. The following tables summarize those derivative balances subject to the right of offset as presented on our Condensed Consolidated Balance Sheets (in millions):
|  | Fair Value as of March 31, 2025
|  | Gross Amounts Recognized |  | Gross Amounts Offset |  | Net Amounts Presented |  | Cash Collateral |  | Gross Amounts without Right of Offset |  | Net Amounts
Assets: |  |  |  |  |  |  |  |  |  |  |  |
Commodities contracts |  | $ | 505.4 |  |  | $ | 271.6 |  |  | $ | 233.9 |  |  | $ | 8.7 |  |  | $ | — |  |  | $ | 225.1 |
Foreign currency contracts |  | 13.5 |  |  | 12.5 |  |  | 0.9 |  |  | — |  |  | — |  |  | 0.9 |
Total assets at fair value |  | $ | 518.9 |  |  | $ | 284.1 |  |  | $ | 234.8 |  |  | $ | 8.7 |  |  | $ | — |  |  | $ | 226.1 |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Commodities contracts |  | $ | 414.9 |  |  | $ | 271.6 |  |  | $ | 143.3 |  |  | $ | 23.5 |  |  | $ | — |  |  | $ | 119.8 |
Foreign currency contracts |  | 21.2 |  |  | 12.5 |  |  | 8.6 |  |  | — |  |  | — |  |  | 8.6 |
Total liabilities at fair value |  | $ | 436.1 |  |  | $ | 284.1 |  |  | $ | 151.9 |  |  | $ | 23.5 |  |  | $ | — |  |  | $ | 128.4 |
|  | Fair Value as of December 31, 2024
|  | Gross Amounts Recognized |  | Gross Amounts Offset |  | Net Amounts Presented |  | Cash Collateral |  | Gross Amounts without Right of Offset |  | Net Amounts
Assets: |  |  |  |  |  |  |  |  |  |  |  |
Commodities contracts |  | $ | 467.6 |  |  | $ | 253.2 |  |  | $ | 214.4 |  |  | $ | 0.1 |  |  | $ | — |  |  | $ | 214.3 |
Interest rate contract |  | 2.9 |  |  | — |  |  | 2.9 |  |  | — |  |  | — |  |  | 2.9 |
Foreign currency contracts |  | 29.1 |  |  | 20.7 |  |  | 8.5 |  |  | — |  |  | — |  |  | 8.5 |
Total assets at fair value |  | $ | 499.6 |  |  | $ | 273.9 |  |  | $ | 225.8 |  |  | $ | 0.1 |  |  | $ | — |  |  | $ | 225.6 |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Commodities contracts |  | $ | 378.7 |  |  | $ | 253.2 |  |  | $ | 125.5 |  |  | $ | 12.1 |  |  | $ | — |  |  | $ | 113.4 |
Foreign currency contracts |  | 22.9 |  |  | 20.7 |  |  | 2.3 |  |  | — |  |  | — |  |  | 2.3 |
Total liabilities at fair value |  | $ | 401.6 |  |  | $ | 273.9 |  |  | $ | 127.8 |  |  | $ | 12.1 |  |  | $ | — |  |  | $ | 115.6 |
At March 31, 2025 and December 31, 2024, we did not present any amounts gross on our Condensed Consolidated Balance Sheets where we had the right of offset. Concentration of Credit Risk Our individual over-the-counter ("OTC") counterparty exposure is managed within predetermined credit limits and includes the use of cash-call margins when appropriate, thereby reducing the risk of significant nonperformance. At March 31, 2025, two of our counterparties with a total exposure of $58.9 million represented over 10% of our credit exposure to OTC derivative counterparties, for which we held cash collateral of $7.0 million. Nonrecurring Fair Value Measurements During the first quarter of 2025, we identified an impairment indicator with respect to the Watson Fuels asset group within the land segment. We determined that the carrying amount was not recoverable and recognized an asset impairment charge of $44.5 million during the three months ended March 31, 2025. The impairment is recorded within Asset impairments on the Condensed Consolidated Statements of Income and Comprehensive Income and reported in our land segment. The fair value of the asset group was determined based on a market approach using the estimated sale proceeds for the Watson Fuels sale. The measurement is categorized as Level 2 within the fair value hierarchy. As discussed in Note 3. Acquisitions and Divestitures, we completed the Watson Fuels sale subsequent to March 31, 2025.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 107 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2E -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 940 -SubTopic 820 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration